| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 06/13/2006 | US7060685 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries |
| 06/13/2006 | US7060683 for treatment of neurodegeneration, stroke, Alzheimer's, amyotrophy, motor neuron damage, acute central nervous system injury, muscular dystrophy, bone resorption, platelet aggregation, cataracts and inflammation |
| 06/13/2006 | US7060681 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 06/08/2006 | WO2006060765A2 Use of a compound that activates a vitamin d receptor for reducing intimal hyperplasia, smooth muscle cell proliferation and restenosis in mammals |
| 06/08/2006 | WO2006058630A1 Cyclic iminocarbamates and use thereof |
| 06/08/2006 | WO2005099671A3 Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
| 06/08/2006 | US20060122374 Albumin-fused anti-angiogenesis peptides |
| 06/08/2006 | US20060122371 Process for preparing cardiodilatin fragments; highly purified cardiodilatin fragments and intermediate products for the preparation of same |
| 06/08/2006 | US20060122249 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 06/08/2006 | US20060122244 Hypoglycemic agents; antidiabetic agentys; side effect reduction; cardiovascular disorders; anticancer agents |
| 06/08/2006 | US20060122234 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 06/08/2006 | US20060122188 Anticoagulants; 2-[1S-(4-(ethoxycarbonyl)piperazin-1-yl)carbonyl-3-carboxypropyl]aminocarbonyl-4-(2-methylthiazol-4-yl)methoxyquinoline; antithrombotic agents in the treatment and prevention of thrombosis |
| 06/08/2006 | US20060122176 such as 5-(1,3-benzodioxol-5-ylmethylene)-1,3-thiazolidine-2,4-dione, used for the treatment and/or prophylaxis of autoimmune, cardiovascular or neurodegenerative disorders, inflammatory or kidney diseases, bacterial or viral infections, platelet aggregation, cancer, transplant rejection or lung injuries |
| 06/08/2006 | US20060122124 Therapeutic agent |
| 06/08/2006 | US20060121514 Prostacyclin-stimulating Factor-2 |
| 06/08/2006 | US20060121180 Using electrochemical solution containing metal compound and bioactive materials; contacting substrate |
| 06/08/2006 | US20060121128 Increasing cytosolic calcium levels in airway epithelial cell by contacting purinergic (P2X) receptors on cell with zinc chloride; cystic fibrosis, asthma, allergies, polycystic kidney disease and salt-sensitive hypertension syndromes, diabetes; drug screening; nasal spray |
| 06/08/2006 | US20060121117 Anti-angiogenic compositions and methods of use |
| 06/08/2006 | US20060121022 an antibody against protein C or activated protein C (aPC) comprising the heavy chain and light chain complementarity determining regions; used for suppressing activation of the blood coagulation system and antiinflammatory activity; therapy for diseases such as thrombosis and sepsis |
| 06/08/2006 | US20060121015 Probiotic bifidobacterium strains |
| 06/08/2006 | DE20122582U1 Zubereitung für Restenoseprophylaxe Preparation for prophylaxis of restenosis |
| 06/08/2006 | DE102004058062A1 Cyclische Iminocarbamate und ihre Verwendung Cyclic Iminocarbamate and their use |
| 06/08/2006 | CA2589740A1 Cyclic iminocarbamates and use thereof |
| 06/08/2006 | CA2588453A1 Use of a compound that activates a vitamin d receptor for reducing intimal hyperplasia, smooth muscle cell proliferation and restenosis in mammals |
| 06/07/2006 | EP1666480A1 Aryl or Heteroaryl Fused Imidazole Compounds as intermediates for Anti-Inflammatory And Analgesic Agents. |
| 06/07/2006 | EP1666478A1 Carbamoyl-type benzofuran derivatives |
| 06/07/2006 | EP1666473A1 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 06/07/2006 | EP1666469A1 Plasminogen activator inhibitor-1 inhibitor |
| 06/07/2006 | EP1666455A1 Amide type carboxamide derivative |
| 06/07/2006 | EP1666071A1 Preparation for the prophylaxis of restenose |
| 06/07/2006 | EP1666070A1 Preparation for the prophylaxis of restenose |
| 06/07/2006 | EP1666047A1 Pharmaceutical compositions comprising nitric oxide-releasing pyrrolidones |
| 06/07/2006 | EP1666028A1 Dry powder compositions having improved dispersivity |
| 06/07/2006 | EP1664089A1 Base-substituted benzylamine analogs for use as coagulation factor xa inhibitors, the production and use thereof |
| 06/07/2006 | EP1663952A1 Abiotic heparin antagonists |
| 06/07/2006 | EP1663299A2 Methods for preventing neurological events |
| 06/07/2006 | EP1663292A1 Formulation of albumin-free erythropoietin |
| 06/07/2006 | EP1663213A1 Substituted oxadiazolidinediones as pai-1 inhibitors |
| 06/07/2006 | EP1663190A1 ((((1h-indol-3yl) methylidene)amino)oxy)acetic acid derivatives and related compounds as pai-1 inhibitors for the treatment of inpairement of the fibrinolytic system and of thrombosis |
| 06/07/2006 | EP1663189A1 4-(phenyl-ethylideneaminoxy-propoxy)-phenyl-acetic acid derivatives and related compounds as pai-1 inhibitors for the treatment of impairement of the fibrinolytic system and of thrombisis |
| 06/07/2006 | EP1663177A1 Topical preparations comprising a hydrophilic carrier and a silicone matrix |
| 06/07/2006 | EP1494999B1 Occlusive composition comprising a poly(2-cyanoacrylate) monomer |
| 06/07/2006 | EP1492789B1 Tropane derivatives as ccr5 modulators |
| 06/07/2006 | EP1406878B1 4-(benzylidene-amino)-3-(methylsulfanyl)-4h-(1, 2, 4) triazin-5-one derivatives having a pde-iv inhibiting and tnf-antagonistic effect for the treatment of cardiac diseases and allergies |
| 06/07/2006 | EP1364023B1 Gene highly expressed in cartilage tissues |
| 06/07/2006 | EP1051620B1 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha |
| 06/07/2006 | EP0939767B1 Porcine factor viii and hybrids thereof |
| 06/07/2006 | CN1784415A Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 06/07/2006 | CN1782083A Novel thrombase-like gene and its use |
| 06/07/2006 | CN1781939A Amidated horseshoe crab anti-endotoxin factor circular analogue peptide molecule, its synthetic method and use |
| 06/07/2006 | CN1781937A Amidated horseshoe crab anti endotoxin factor linear analogue peptide molecule, its synthetic method and use |
| 06/07/2006 | CN1781920A Polycyclic guanine phosphodiesterase v inhibitor |
| 06/07/2006 | CN1781919A Method for producing by stereospecific hydration tetrahydropterins and optically pure derivatives, in particular tetrahydrofolic acid and its optically pure derivatives |
| 06/07/2006 | CN1781531A Dragon's blood oil agent, soft capsule containing said oil agent and its preparing method |
| 06/07/2006 | CN1781512A Method for preparing Chinese angelica blood supplementing micro pill |
| 06/07/2006 | CN1781509A Composition of luffa seed oil |
| 06/07/2006 | CN1781506A American ginseng and royal jelly soft capsule |
| 06/07/2006 | CN1258366C Chinese medicine composition for treating gynecopathy and its use |
| 06/06/2006 | US7057044 Aporphine and oxoaporphine compounds and pharmaceutical use thereof |
| 06/06/2006 | US7056944 Pyrazole compositions useful as inhibitors of erk |
| 06/06/2006 | US7056933 For therapy of arthritis, fever, common cold, dysmenorrhea, menstrual cramps, inflammatory bowel disease, Crohn's disease, emphysema, acute respiratory distress syndrome, asthma, bronchitis, chronic obstructive pulmonary disease, etc. |
| 06/06/2006 | US7056926 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, particularly those diseases related to thrombosis |
| 06/06/2006 | US7056923 Anticoagulants |
| 06/06/2006 | US7056910 1,4,5.6-tetrahydroimidazo[4,5-d]diazepine derivatives or salts thereof |
| 06/06/2006 | US7056904 Therapy for bone disorders; osteoporosis; vitamin deficiency |
| 06/06/2006 | US7056903 Administering a therapeutical carbamate derivative to a patient as prostaglandin IP (12 or PGI2) antagonists |
| 06/06/2006 | US7056885 Fibroblast growth factor and nucleic acids encoding same |
| 06/06/2006 | US7056884 Reduced FK228 and use thereof |
| 06/06/2006 | US7056722 Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby |
| 06/06/2006 | US7056514 Partial peptide mimetics and methods |
| 06/06/2006 | CA2367105C A thrombin blood fraction for use in a medical procedure |
| 06/06/2006 | CA2367024C A thrombin blood fraction for use in a medical procedure |
| 06/06/2006 | CA2154788C Anticoagulant composition |
| 06/06/2006 | CA2136903C Acetic acid derivatives |
| 06/06/2006 | CA1341506C Factor viii coagulant polypeptides and monoclonal antibodies to them |
| 06/01/2006 | WO2006057868A1 Antithrombotic diamides |
| 06/01/2006 | WO2006057845A1 Aromatic ether derivatives useful as thrombin inhibitors |
| 06/01/2006 | WO2006057270A1 Nitrogeneous tricyclic compound |
| 06/01/2006 | WO2006056759A1 Modulation of blood clotting |
| 06/01/2006 | WO2006023866A3 Thiazolo-naphthyl acids as inhibitors of plasminogen activator inhibitor-1 |
| 06/01/2006 | WO2004004656A3 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
| 06/01/2006 | WO2003025542A3 Immune response associated proteins |
| 06/01/2006 | US20060117414 Fad4, Fad5, Fad5-2, and Fad6, novel fatty acid desaturase family members and uses thereof |
| 06/01/2006 | US20060116388 CXCR3 antagonists |
| 06/01/2006 | US20060116361 5-Amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation |
| 06/01/2006 | US20060115542 Therapeutic delivery of carbon monoxide |
| 06/01/2006 | US20060115376 Irradiation in presence of stabilizer; preventing degradation |
| 06/01/2006 | CA2579962A1 Glycine as a diet supplement for the treatment of health problems that result from underlying metabolic disorders |
| 05/31/2006 | EP1661984A1 Method of differentiation from embryo-stem cell of primate to hematogenous cell |
| 05/31/2006 | EP1660482A1 3- [(2-{ 4-(hexyloxycarbonylamino-imino-methyl)-phenylamino] -methyl}-1-methyl-1h -benzimidazol-5-car bonyl)-pyridine-2-yl-amino -propionic acid ethyl ester metha ne sulphonate and use thereof as a medicament |
| 05/31/2006 | EP1660115A1 Pharmaceutical combination of g-csf and plgf useful for blood stem cell |
| 05/31/2006 | EP1660113A1 A method of producing an anticoagulation effect |
| 05/31/2006 | EP1660105A1 Method of replenishing cells damaged by treatment for cancer |
| 05/31/2006 | EP1660070A2 Selected betaines and their uses |
| 05/31/2006 | EP1413305B1 Aryl (or heteroaryl) azolylcarbynol derivatives for the treatment of urinary incontinence |
| 05/31/2006 | EP1268798B1 Anti-angiogenic properties of vascostatin and fragments or variants thereof |
| 05/31/2006 | EP1105410A4 Purification of blood clotting proteins |
| 05/31/2006 | EP0891426B1 Human bikunin |
| 05/31/2006 | CN1780637A Liquid, aqueous, pharmaceutical compositions of factor VII polypeptides |
| 05/31/2006 | CN1778917A RNA interference fragment and its use |